• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Caredx Inc (NQ: CDNA )

    8.250 +0.050 (+0.61%)
    Streaming Delayed Price Updated: 10:06 AM EDT, Apr 30, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 33,242
    Open 8.000
    Bid (Size) 8.250 (1)
    Ask (Size) 8.290 (4)
    Prev. Close 8.200
    Today's Range 7.740 - 8.250
    52wk Range 4.800 - 12.93
    Shares Outstanding 52,627,165
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    CareDx to Report First Quarter 2024 Financial Results
    From CareDx, Inc.
    Via Business Wire
    CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
    From CareDx, Inc.
    Via Business Wire

    Performance

    YTD
    -30.90%
    -30.90%
    1 Month
    -20.06%
    -20.06%
    3 Month
    -16.50%
    -16.50%
    6 Month
    +60.19%
    +60.19%
    1 Year
    -0.60%
    -0.60%

    More News

    Read More
    CareDx Appoints John W. Hanna as its New President and Chief Executive Officer
    From CareDx, Inc.
    Via Business Wire
    CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting
    From CareDx, Inc.
    Via Business Wire
    Recap: CareDx Q4 Earnings
    Via Benzinga
    Earnings Outlook For CareDx
    Via Benzinga
    CareDx Appoints Bryan Riggsbee to Its Board of Directors
    From CareDx, Inc.
    Via Business Wire
    CareDx Announces Fourth Quarter and Full Year 2023 Financial Results
    From CareDx, Inc.
    Via Business Wire
    CareDx to Participate in the Raymond James & Associates’ 45th Annual Institutional Investors Conference
    From CareDx, Inc.
    Via Business Wire
    CareDx to Report Fourth Quarter and Full Year 2023 Financial Results
    From CareDx, Inc.
    Via Business Wire
    CareDx: Q3 Earnings Insights
    Via Benzinga
    Earnings Outlook For CareDx
    Via Benzinga
    CareDx Showcases Digital Solutions and Pipeline in Cellular Transplant and Therapy Monitoring at the 2024 Tandem Meetings
    From CareDx, Inc.
    Via Business Wire
    3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List
    Via InvestorPlace
    CareDx Issues Statement in Patent Infringement Case
    From CareDx, Inc.
    Via Business Wire
    Natera Hits A Nearly Two-Year High After Notching A Win In A Patent Battle
    Via Investor's Business Daily
    Topics Intellectual Property
    Exposures Intellectual Property
    CareDx Adds to AlloSure Kidney and HeartCare Utility and Clinical Data at 2024 American Society of Transplant Surgeons Winter Symposium
    From CareDx, Inc.
    Via Business Wire
    CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2023
    From CareDx, Inc.
    Via Business Wire
    CareDx Joins Forces with the National Foundation for Transplants to Improve Post-Transplant Medication Adherence
    From CareDx, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    CareDx Reports Third Quarter 2023 Results
    From CareDx, Inc.
    Via Business Wire
    CareDx to Report Third Quarter 2023 Financial Results
    From CareDx, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    CareDx Announces CEO Transition
    From CareDx, Inc.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.